GRAL
GRAIL Inc · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website grail.com
- Employees(FY) -
- ISIN US3847471014
Performance
-14.37%
1W
-25.96%
1M
-7.1%
3M
-7.1%
6M
-7.1%
YTD
-7.1%
1Y
Profile
GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.
Recent News & Updates
- 2024-09-02 23:37
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal(Yahoo Finance)
- 2024-08-30 05:55
- 2024-08-29 16:16
- 2024-08-29 04:16
- 2024-08-22 16:11
- 2024-08-22 16:10
- 2024-08-21 16:01
- 2024-08-21 04:01
- 2024-08-17 10:05
- 2024-08-16 08:01
10 Cheap Robotics Stocks To Buy(Insidermonkey)
- 2024-08-14 08:07
Grail to shed 350 workers in restructuring(MedTech Dive)
- 2024-08-13 17:16
- 2024-08-13 16:01
- 2024-08-13 04:01
- 2024-08-08 08:05
- 2024-08-07 20:05
- 2024-07-31 16:05
- 2024-07-31 04:05
- 2024-07-23 20:55
Heres Why You Should Add Illumina (ILMN) to Your Portfolio(Yahoo Finance)
- 2024-07-19 06:53
Grail announces first patients enrolled in REACH cancer trial(Medical Device Network)
- 2024-07-18 09:00
- 2024-07-17 21:00
- 2024-07-17 06:30
3 Top Cancer Treatment Stocks to Buy Now(InvestorPlace)
- 2024-07-15 12:31
3 Spinoff Stocks You Should Buy Now: July 2024(InvestorPlace)
- 2024-07-15 09:14
- 2024-07-15 03:53
- 2024-07-15 03:01
- 2024-07-15 00:31
3 Spinoff Stocks You Should Buy Now: July 2024(Investorplace)
- 2024-07-14 15:01
- 2024-07-05 06:55
3 Biotech Stocks Turning DNA Dreams Into Dollars(InvestorPlace)
Page 1 of 2
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.